Generic selectors
Exact matches only
Search in title
Search in content
Search in posts
Search in pages
Filter by Categories

Series B

Elicio aligns itself with Livzon for $33m
Livzon Pharmaceutical Group has been identified as an investor by MIT spinout Elicio Therapeutics, which just completed a series B round that takes its total financing to $63m.
Tenaya inspires investors for $92m series B
GV has contributed to a $92m series B for Tenaya, three years after it was spun out of Gladstone Institutes and University of Texas Southwestern Medical Center.
Tulip unfolds series B round
DMG Mori, an existing customer of MIT spinout Tulip, has contributed to a round that closed at $39.5m, alongside Vertex Ventures, NEA and Pitango.
Versantis revisits investors for $16.2m
ETH Zurich’s Versantis picked up series B funding from Zürcher Kantonalbank among other returning investors to bring its total to $20.6m.
Daily deal net: September 19, 2019
Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.
OncoCell celebrates $22.2m series B
Immonogenomics blood test developer OncoCell, a Harvard Medical School spinout, has increased its total funding to $30m.
Keranova carries over funding from Institut Mérieux
Institut Mérieux has returned for a $26.5m round for surgical technology developer Keranova, having previously supported a $4.6m round three and a half years ago.
Ori aligns $20m
MIT-founded robotic interior design developer Ori found support from Sidewalk Labs and Ingka Group as it looks to deliver full robotic interiors in partnership with architects and property developers.

Other News

Daily deal net: September 9, 2019
Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.
Leyue Health lays out $16.1m series B
Chinese Academy of Sciences’ Investment Management unit put up a share of the proceeds for health insurance data analytics company Leyue Health’s series B round.
Passage Bio packs in another $110m
University of Pennsylvania-allied CNS disease therapy developer Passage Bio lured contributions from investors including Lilly Asia Ventures, which also featured in its $116m series A earlier this year.
Cartica AI clinches series B funding
Cartica AI, an autonomous perception tech developer forged from Technion spinout Cortica, secured capital from OurCrowd, Continental, Toyota and BMW in what appears to be its first publicly-disclosed round.
Gyroscope spins to series B round
Gyroscope Therapeutics, a dry AMD treatment developer exploiting University of Cambridge research, has secured $61.2m from cornerstone investors Cambridge Innovation Capital and Syncona.
Achilles Therapeutics accesses $120m
UCL and Francis Crick-founded Achilles has raised series B funding at a reported $228m valuation and will now look to advance lung cancer and melanoma treatments.

Editor's Picks

Big deal: Ribon ties together $65m series B
Ribon Therapeutics has emerged out of stealth after three years of developing a lead asset targeting cancer based on research at MIT, UT Southwestern and Harvard Medical School.
Canvas paints $9m picture
Canvas Network, an online education platform developed by learning management software (LMS) provider Instructure which received $9.1m investment for the platform, has begun offering free and open online courses.
WRF finds its Resolve
In May 2010, Resolve raised $2m in the initial close of its A round before bringing in a corporate venturing unit later.
Imperial helps PsiOxus raise $34m
UK-listed investment fund Imperial Innovations joins GlaxoSmithKline's SR One, fund manager Invesco Perpetual and Lundbeckfond Ventures, backing the d cancer treatment company.
test reg